Get published

From Clinical to Commercial: Streamlining Cold Chain Logistics for Advanced Therapies

Cell and gene therapy (CGT) products require ultra-cold temperatures throughout manufacturing and distribution, posing significant challenges when transitioning from clinical development to commercialization.

This article discusses the critical role of cold chain logistics in preserving product integrity, managing global distribution, and maintaining compliance with complex regulatory standards.

Thermo Fisher Scientific offers comprehensive solutions to address the demands of CGT logistics. The article also presents a case study highlighting the seamless transition of an allogeneic cell therapy from clinical to commercial stages. It emphasizes just-in-time packaging, regulatory navigation, and commercial scalability - key factors that support growth in the CGT sector.

Download Now

By submitting this form, you agree to the Terms & Conditions and acknowledge that your personal information will be processed in accordance with the Privacy Statement.

Sponsored by:

From Clinical to Commercial: Streamlining Cold Chain Logistics for Advanced Therapies

Cell and gene therapy (CGT) products require ultra-cold temperatures throughout manufacturing and distribution, posing significant challenges when transitioning from clinical development to commercialization.

Download Now